Forkhead Box P Family Members at the Crossroad Between Tolerance and Immunity: A Balancing Act

REFERENCES

• Germain RN. Maintaining system homeostasis: the third law of Newtonian immunology. Nat Immunol 2012;13(10):902–906.
   Google Scholar
• Goldszmid RS, Trinchieri G. The price of immunity. Nat Immunol 2012;13(10):932–938.
   PubMed Web of Science ®Google Scholar
• Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 2005;6(4):331–337.
   PubMed Web of Science ®Google Scholar
• Brunkow ME, Jeffery EW, Hjerrild KA, Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001;27(1):68–73.
   PubMed Web of Science ®Google Scholar
• Bennett CL, Christie J, Ramsdell F, The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001;27(1):20–21.
   PubMed Web of Science ®Google Scholar
• Chatila TA, Blaeser F, Ho N, JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 2000;106(12):R75–R81.
   PubMed Web of Science ®Google Scholar
• Wildin RS, Ramsdell F, Peake J, X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001;27(1):18–20.
   PubMed Web of Science ®Google Scholar
• Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25 +regulatory T cells. Nat Immunol 2003;4(4):330–336.
   PubMed Web of Science ®Google Scholar
• Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003;4(4):337–342.
   PubMed Web of Science ®Google Scholar
• Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299(5609):1057–1061.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Sakaguchi N, Asano M, Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155(3):1151–1164.
   PubMed Web of Science ®Google Scholar
• Curotto de Lafaille MA, Lafaille JJ. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 2009;30(5):626–635.
   Google Scholar
• Hannenhalli S, Kaestner KH. The evolution of Fox genes and their role in development and disease. Nat Rev Genet 2009;10(4):233–240.
   Web of Science ®Google Scholar
• Kaestner KH, Knochel W, Martinez DE. Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev 2000;14(2):142–146.
   Google Scholar
• Coffer PJ, Burgering BM. Forkhead-box transcription factors and their role in the immune system. Nat Rev Immunol 2004;4(11):889–899.
   PubMed Web of Science ®Google Scholar
• Li S, Zhou D, Lu MM, Morrisey EE. Advanced cardiac morphogenesis does not require heart tube fusion. Science 2004;305(5690):1619–1622.
   Google Scholar
• Wang B, Weidenfeld J, Lu MM, Foxp1 regulates cardiac outflow tract, endocardial cushion morphogenesis and myocyte proliferation and maturation. Development 2004;131(18):4477–4487.
   PubMed Web of Science ®Google Scholar
• Shu W, Cho JY, Jiang Y, Altered ultrasonic vocalization in mice with a disruption in the Foxp2 gene. Proc Natl Acad Sci USA 2005;102(27):9643–9648.
   Google Scholar
• Enard W, Przeworski M, Fisher SE, Molecular evolution of FOXP2, a gene involved in speech and language. Nature 2002;418(6900):869–872.
   PubMed Web of Science ®Google Scholar
• Hamdan FF, Daoud H, Rochefort D, De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment. Am J Hum Genet 2010;87(5):671–678.
   Google Scholar
• Katoh H, Zheng P, Liu Y. FOXP3: Genetic and epigenetic implications for autoimmunity. J Autoimmun 2013;41:72–78.
   Google Scholar
• Lai CS, Fisher SE, Hurst JA, A forkhead-domain gene is mutated in a severe speech and language disorder. Nature 2001;413(6855):519–523.
   PubMed Web of Science ®Google Scholar
• MacDermot KD, Bonora E, Sykes N, Identification of FOXP2 truncation as a novel cause of developmental speech and language deficits. Am J Hum Genet 2005;76(6): 1074–1080.
   PubMed Web of Science ®Google Scholar
• Ernst T, Score J, Deininger M, Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemia. Br J Haematol 2011;153(1):43–46.
   Google Scholar
• Goatly A, Bacon CM, Nakamura S, FOXP1 abnormalities in lymphoma: translocation breakpoint mapping reveals insights into deregulated transcriptional control. Mod Pathol 2008;21(7):902–911.
   Google Scholar
• Streubel B, Vinatzer U, Lamprecht A, T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia 2005;19(4):652–658.
   PubMed Web of Science ®Google Scholar
• Campbell AJ, Lyne L, Brown PJ, Aberrant expression of the neuronal transcription factor FOXP2 in neoplastic plasma cells. Br J Haematol 2010;149(2):221–230.
   Google Scholar
• Howarth KD, Blood KA, Ng BL, Array painting reveals a high frequency of balanced translocations in breast cancer cell lines that break in cancer-relevant genes. Oncogene 2008;27(23):3345–3359.
   Google Scholar
• Zuo T, Wang L, Morrison C, FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene. Cell 2007;129(7):1275–1286.
   PubMed Web of Science ®Google Scholar
• Banham AH, Connors JM, Brown PJ, Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma. Clin Cancer Res 2005;11(3):1065–1072.
   PubMed Web of Science ®Google Scholar
• Wiehagen KR, Corbo-Rodgers E, Li S, Foxp4 is dispensable for T cell development, but required for robust recall responses. PLoS One 2012;7(8):e42273.
   Google Scholar
• Koon HB, Ippolito GC, Banham AH, Tucker PW. FOXP1: a potential therapeutic target in cancer. Expert Opin Ther Targets 2007;11(7):955–965.
   PubMed Web of Science ®Google Scholar
• Feng X, Ippolito GC, Tian L, Foxp1 is an essential transcriptional regulator for the generation of quiescent naive T cells during thymocyte development. Blood 2010;115(3):510–518.
   Google Scholar
• Hu H, Wang B, Borde M, Foxp1 is an essential transcriptional regulator of B cell development. Nat Immunol 2006;7(8):819–826.
   PubMed Web of Science ®Google Scholar
• Li C, Tucker PW. DNA-binding properties and secondary structural model of the hepatocyte nuclear factor 3/fork head domain. Proc Natl Acad Sci USA 1993;90(24):11583–11587.
   Google Scholar
• Stroud JC, Wu Y, Bates DL, Structure of the forkhead domain of FOXP2 bound to DNA. Structure 2006;14(1):159–166.
   PubMed Web of Science ®Google Scholar
• Wang B, Lin D, Li C, Tucker P. Multiple domains define the expression and regulatory properties of Foxp1 forkhead transcriptional repressors. J Biol Chem 2003;278(27):24259–24268.
   Google Scholar
• Lopes JE, Torgerson TR, Schubert LA, Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor. J Immunol 2006;177(5):3133–3142.
   PubMed Web of Science ®Google Scholar
• Chae WJ, Henegariu O, Lee SK, Bothwell AL. The mutant leucine-zipper domain impairs both dimerization and suppressive function of Foxp3 in T cells. Proc Natl Acad Sci USA 2006;103(25):9631–9636.
   Google Scholar
• Li S, Weidenfeld J, Morrisey EE. Transcriptional and DNA binding activity of the Foxp1/2/4 family is modulated by heterotypic and homotypic protein interactions. Mol Cell Biol 2004;24(2):809–822.
   PubMed Web of Science ®Google Scholar
• Li B, Samanta A, Song X, FOXP3 is a homo-oligomer and a component of a supramolecular regulatory complex disabled in the human XLAAD/IPEX autoimmune disease. Int Immunol 2007;19(7):825–835.
   Google Scholar
• Bandukwala HS, Wu Y, Feuerer M, Structure of a domain-swapped FOXP3 dimer on DNA and its function in regulatory T cells. Immunity 2011;34(4):479–491.
   PubMed Web of Science ®Google Scholar
• Wu Y, Borde M, Heissmeyer V, FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 2006;126(2):375–387.
   PubMed Web of Science ®Google Scholar
• Lalmansingh AS, Karmakar S, Jin Y, Nagaich AK. Multiple modes of chromatin remodeling by Forkhead box proteins. Biochim Biophys Acta 2012;1819(7):707–715.
   Google Scholar
• Bacchetta R, Passerini L, Gambineri E, Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J Clin Invest 2006;116(6):1713–1722.
   PubMed Web of Science ®Google Scholar
• Du J, Huang C, Zhou B, Ziegler SF. Isoform-specific inhibition of ROR alpha-mediated transcriptional activation by human FOXP3. J Immunol 2008;180(7):4785–4792.
   Google Scholar
• Zhou L, Lopes JE, Chong MM, TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008;453(7192):236–240.
   PubMed Web of Science ®Google Scholar
• Eijkelenboom A, Burgering BM. FOXOs: signalling integrators for homeostasis maintenance. Nat Rev Mol Cell Biol 2013;14(2):83–97.
   PubMed Web of Science ®Google Scholar
• Wijchers PJ, Burbach JP, Smidt MP. In control of biology: of mice, men and Foxes. Biochem J 2006;397(2):233–246.
   Google Scholar
• Vernes SC, Nicod J, Elahi FM, Functional genetic analysis of mutations implicated in a human speech and language disorder. Hum Mol Genet 2006;15(21):3154–3167.
   Google Scholar
• Hancock WW, Ozkaynak E. Three distinct domains contribute to nuclear transport of murine Foxp3. PLoS One 2009;4(11):e7890.
   Google Scholar
• Schaefer MH, Wanker EE, Andrade-Navarro MA. Evolution and function of CAG/polyglutamine repeats in protein-protein interaction networks. Nucleic Acids Res 2012;40(10):4273–4287.
   Google Scholar
• Shu W, Yang H, Zhang L, Characterization of a new subfamily of winged-helix/forkhead (Fox) genes that are expressed in the lung and act as transcriptional repressors. J Biol Chem 2001;276(29):27488–27497.
   PubMed Web of Science ®Google Scholar
• Lu MM, Li S, Yang H, Morrisey EE. Foxp4: a novel member of the Foxp subfamily of winged-helix genes co-expressed with Foxp1 and Foxp2 in pulmonary and gut tissues. Mech Dev 2002;119(Suppl 1):S197–S202.
   Google Scholar
• Teufel A, Wong EA, Mukhopadhyay M, FoxP4, a novel forkhead transcription factor. Biochim Biophys Acta 2003;1627(2–3):147–152.
   Google Scholar
• Ferland RJ, Cherry TJ, Preware PO, Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature brain. J Comp Neurol 2003;460(2):266–279.
   Google Scholar
• Shu W, Lu MM, Zhang Y, et al.. Foxp2 and Foxp1 cooperatively regulate lung and esophagus development. Development 2007;134(10):1991–2000.
   Google Scholar
• Banham AH, Beasley N, Campo E, The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p. Cancer Res 2001;61(24):8820–8829.
   PubMed Web of Science ®Google Scholar
• Shi C, Zhang X, Chen Z, Integrin engagement regulates monocyte differentiation through the forkhead transcription factor Foxp1. J Clin Invest 2004;114(3):408–418.
   Google Scholar
• Fuxa M, Skok JA. Transcriptional regulation in early B cell development. Curr Opin Immunol 2007;19(2):129–136.
   Google Scholar
• Walker MR, Kasprowicz DJ, Gersuk VH, Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J Clin Invest 2003;112(9):1437–1443.
   PubMed Web of Science ®Google Scholar
• Gavin MA, Torgerson TR, Houston E, Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci USA 2006;103(17):6659–6664.
   PubMed Web of Science ®Google Scholar
• Wang J, Ioan-Facsinay A, van der Voort EI, Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 2007;37(1):129–138.
   PubMed Web of Science ®Google Scholar
• Burchill MA, Yang J, Vogtenhuber C, IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J Immunol 2007;178(1):280–290.
   PubMed Web of Science ®Google Scholar
• Tone Y, Furuuchi K, Kojima Y, Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol 2008;9(2):194–202.
   PubMed Web of Science ®Google Scholar
• Yao Z, Kanno Y, Kerenyi M, Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood 2007;109(10):4368–4375.
   PubMed Web of Science ®Google Scholar
• Deenick EK, Elford AR, Pellegrini M, c-Rel but not NF-kappaB1 is important for T regulatory cell development. Eur J Immunol 2010;40(3):677–681.
   Google Scholar
• Mantel PY, Ouaked N, Ruckert B, Molecular mechanisms underlying FOXP3 induction in human T cells. J Immunol 2006;176(6):3593–3602.
   PubMed Web of Science ®Google Scholar
• Visekruna A, Huber M, Hellhund A, c-Rel is crucial for the induction of Foxp3(+) regulatory CD4(+) T cells but not T(H)17 cells. Eur J Immunol 2010;40(3):671–676.
   Google Scholar
• Zheng Y, Josefowicz S, Chaudhry A, Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 2010;463(7282):808–812.
   PubMed Web of Science ®Google Scholar
• Kitoh A, Ono M, Naoe Y, Indispensable role of the Runx1-Cbfbeta transcription complex for in vivo-suppressive function of FoxP3 +regulatory T cells. Immunity 2009;31(4):609–620.
   PubMed Web of Science ®Google Scholar
• Ono M, Yaguchi H, Ohkura N, Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 2007;446(7136):685–689.
   PubMed Web of Science ®Google Scholar
• Rudra D, Egawa T, Chong MM, Runx-CBFbeta complexes control expression of the transcription factor Foxp3 in regulatory T cells. Nat Immunol 2009;10(11):1170–1177.
   PubMed Web of Science ®Google Scholar
• Baron U, Floess S, Wieczorek G, DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur J Immunol 2007;37(9):2378–2389.
   PubMed Web of Science ®Google Scholar
• Floess S, Freyer J, Siewert C, Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 2007;5(2):e38.
   PubMed Web of Science ®Google Scholar
• Janson PC, Winerdal ME, Marits P, FOXP3 promoter demethylation reveals the committed Treg population in humans. PLoS One 2008;3(2):e1612.
   PubMed Web of Science ®Google Scholar
• Polansky JK, Kretschmer K, Freyer J, DNA methylation controls Foxp3 gene expression. Eur J Immunol 2008;38(6):1654–1663.
   PubMed Web of Science ®Google Scholar
• Bot PT, Grundmann S, Goumans MJ, Forkhead box protein P1 as a downstream target of transforming growth factor-beta induces collagen synthesis and correlates with a more stable plaque phenotype. Atherosclerosis 2011;218(1):33–43.
   Google Scholar
• Brown PJ, Ashe SL, Leich E, Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL. Blood 2008;111(5):2816–2824.
   Google Scholar
• Ouyang W, Beckett O, Ma Q, Foxo proteins cooperatively control the differentiation of Foxp3 +regulatory T cells. Nat Immunol 2010;11(7):618–627.
   PubMed Web of Science ®Google Scholar
• Ouyang W, Li MO. Foxo: in command of T lymphocyte homeostasis and tolerance. Trends Immunol 2011;32(1):26–33.
   PubMed Web of Science ®Google Scholar
• Ouyang W, Liao W, Luo CT, Novel Foxo1-dependent transcriptional programs control T(reg) cell function. Nature 2012;491(7425):554–559.
   PubMed Web of Science ®Google Scholar
• Santos ME, Athanasiadis A, Leitao AB, Alternative splicing and gene duplication in the evolution of the FoxP gene subfamily. Mol Biol Evol 2011;28(1):237–247.
   Google Scholar
• Gabut M, Samavarchi-Tehrani P, Wang X, An alternative splicing switch regulates embryonic stem cell pluripotency and reprogramming. Cell 2011;147(1):132–146.
   PubMed Web of Science ®Google Scholar
• Quesada V, Conde L, Villamor N, Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 2012;44(1):47–52.
   Web of Science ®Google Scholar
• Ziegler SF. FOXP3: of mice and men. Annu Rev Immunol 2006;24:209–226.
   PubMed Web of Science ®Google Scholar
• Li B, Samanta A, Song X, FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. Proc Natl Acad Sci USA 2007;104(11):4571–4576.
   PubMed Web of Science ®Google Scholar
• van Loosdregt J, Vercoulen Y, Guichelaar T, Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization. Blood 2010;115(5):965–974.
   PubMed Web of Science ®Google Scholar
• Kwon HS, Lim HW, Wu J, Three novel acetylation sites in the Foxp3 transcription factor regulate the suppressive activity of regulatory T cells. J Immunol 2012;188(6):2712–2721.
   PubMed Web of Science ®Google Scholar
• Song X, Li B, Xiao Y, Structural and biological features of FOXP3 dimerization relevant to regulatory T cell function. Cell Rep 2012;1(6):665–675.
   Google Scholar
• van Loosdregt J, Brunen D, Fleskens V, Rapid temporal control of Foxp3 protein degradation by sirtuin-1. PLoS One 2011;6(4):e19047.
   Google Scholar
• Williams LM, Rudensky AY. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol 2007;8(3):277–284.
   PubMed Web of Science ®Google Scholar
• Hancock WW, Akimova T, Beier UH, HDAC inhibitor therapy in autoimmunity and transplantation. Ann Rheum Dis 2012;71(Suppl 2):i46–i54.
   Google Scholar
• Zhou X, Bailey-Bucktrout SL, Jeker LT, Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 2009;10(9):1000–1007.
   PubMed Web of Science ®Google Scholar
• Hornbeck PV, Kornhauser JM, Tkachev S, PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res 2012;40(Database issue):D261–D270.
   PubMed Web of Science ®Google Scholar
• Xue ZH, Zhao CQ, Chua GL, Integrin alphaMbeta2 clustering triggers phosphorylation and activation of protein kinase C delta that regulates transcription factor Foxp1 expression in monocytes. J Immunol 2010;184(7):3697–3709.
   Google Scholar
• Delgoffe GM, Kole TP, Zheng Y, The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 2009;30(6):832–844.
   PubMed Web of Science ®Google Scholar
• Battaglia M, Stabilini A, Roncarolo MG. Rapamycin selectively expands CD4+CD25+FoxP3 +regulatory T cells. Blood 2005;105(12):4743–4748.
   PubMed Web of Science ®Google Scholar
• Marson A, Kretschmer K, Frampton GM, Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 2007;445(7130):931–935.
   Google Scholar
• Zheng Y, Josefowicz SZ, Kas A, Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 2007;445(7130):936–940.
   PubMed Web of Science ®Google Scholar
• Koh KP, Sundrud MS, Rao A. Domain requirements and sequence specificity of DNA binding for the forkhead transcription factor FOXP3. PLoS One 2009;4(12):e8109.
   Google Scholar
• Vernes SC, Spiteri E, Nicod J, High-throughput analysis of promoter occupancy reveals direct neural targets of FOXP2, a gene mutated in speech and language disorders. Am J Hum Genet 2007;81(6):1232–1250.
   Google Scholar
• Shi Y, Sawada J, Sui G, Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 2003;422(6933):735–738.
   PubMed Web of Science ®Google Scholar
• Pan F, Yu H, Dang EV, Eos mediates Foxp3-dependent gene silencing in CD4 +regulatory T cells. Science 2009;325(5944):1142–1146.
   PubMed Web of Science ®Google Scholar
• Offner H, Vandenbark AA. Congruent effects of estrogen and T-cell receptor peptide therapy on regulatory T cells in EAE and MS. Int Rev Immunol 2005;24(5–6):447–477.
   PubMed Web of Science ®Google Scholar
• Polanczyk MJ, Carson BD, Subramanian S, Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment. J Immunol 2004;173(4):2227–2230.
   PubMed Web of Science ®Google Scholar
• Polanczyk MJ, Hopke C, Huan J, Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice. J Neuroimmunol. 2005;170(1–2):85–92.
   Google Scholar
• Banham AH, Boddy J, Launchbury R, Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia. Prostate 2007;67(10):1091–1098.
   Google Scholar
• Shigekawa T, Ijichi N, Ikeda K, FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancer. Horm Cancer 2011;2(5):286–297.
   Google Scholar
• Chokas AL, Trivedi CM, Lu MM, Foxp1/2/4-NuRD interactions regulate gene expression and epithelial injury response in the lung via regulation of interleukin-6. J Biol Chem 2010;285(17):13304–13313.
   Google Scholar
• Samstein RM, Arvey A, Josefowicz SZ, Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell 2012;151(1):153–166.
   PubMed Web of Science ®Google Scholar
• Jepsen K, Gleiberman AS, Shi C, Cooperative regulation in development by SMRT and FOXP1. Genes Dev 2008;22(6):740–745.
   Google Scholar
• Birzele F, Fauti T, Stahl H, Next-generation insights into regulatory T cells: expression profiling and FoxP3 occupancy in Human. Nucleic Acids Res 2011;39(18):7946–7960.
   Google Scholar
• Sadlon TJ, Wilkinson BG, Pederson S, Genome-wide identification of human FOXP3 target genes in natural regulatory T cells. J Immunol 2010;185(2):1071–1081.
   PubMed Web of Science ®Google Scholar
• Gavin MA, Rasmussen JP, Fontenot JD, Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007;445(7129):771–775.
   PubMed Web of Science ®Google Scholar
• Lin W, Haribhai D, Relland LM, Regulatory T cell development in the absence of functional Foxp3. Nat Immunol 2007;8(4):359–368.
   PubMed Web of Science ®Google Scholar
• Spiteri E, Konopka G, Coppola G, Identification of the transcriptional targets of FOXP2, a gene linked to speech and language, in developing human brain. Am J Hum Genet 2007;81(6):1144–1157.
   Google Scholar
• Tang B, Becanovic K, Desplats PA, Forkhead box protein p1 is a transcriptional repressor of immune signaling in the CNS: implications for transcriptional dysregulation in Huntington disease. Hum Mol Genet 2012;21(14):3097–3111.
   Google Scholar
• Schubert LA, Jeffery E, Zhang Y, Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem 2001;276(40):37672–37679.
   PubMed Web of Science ®Google Scholar
• Malek TR, Castro I. Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity 2010;33(2):153–165.
   PubMed Web of Science ®Google Scholar
• Bettelli E, Dastrange M, Oukka M. Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci USA 2005;102(14):5138–5143.
   PubMed Web of Science ®Google Scholar
• Shevach EM. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 2009;30(5):636–645.
   PubMed Web of Science ®Google Scholar
• Carrette F, Surh CD. IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis. Semin Immunol 2012;24(3):209–217.
   PubMed Web of Science ®Google Scholar
• Feng X, Wang H, Takata H, Transcription factor Foxp1 exerts essential cell-intrinsic regulation of the quiescence of naive T cells. Nat Immunol 2011;12(6):544–550.
   PubMed Web of Science ®Google Scholar
• Liu W, Putnam AL, Xu-Yu Z, CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006;203(7):1701–1711.
   PubMed Web of Science ®Google Scholar
• Seddiki N, Santner-Nanan B, Martinson J, Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006;203(7):1693–1700.
   PubMed Web of Science ®Google Scholar
• Hoffmann P, Boeld TJ, Eder R, Loss of FOXP3 expression in natural human CD4+CD25 +regulatory T cells upon repetitive in vitro stimulation. Eur J Immunol 2009;39(4):1088–1097.
   PubMed Web of Science ®Google Scholar
• Wan YY, Flavell RA. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 2007;445(7129):766–770.
   PubMed Web of Science ®Google Scholar
• McMurchy AN, Gillies J, Gizzi MC, A novel function for FOXP3 in humans: intrinsic regulation of conventional T cells. Blood 2013;121(8):1265–1275.
   Google Scholar
• Chen Z, Xiao Y, Zhang J, Transcription factors E2A, FOXO1 and FOXP1 regulate recombination activating gene expression in cancer cells. PLoS One 2011;6(5):e20475.
   Google Scholar
• von Boehmer H, Daniel C. Therapeutic opportunities for manipulating T(Reg) cells in autoimmunity and cancer. Nat Rev Drug Discov 2012;12(1):51–63.
   Google Scholar
• Beier UH, Wang L, Han R, Histone deacetylases 6 and 9 and sirtuin-1 control Foxp3+ regulatory T cell function through shared and isoform-specific mechanisms. Sci Signal 2012;5(229):ra45.
   PubMed Web of Science ®Google Scholar
• Karanikas V, Speletas M, Zamanakou M, Foxp3 expression in human cancer cells. J Transl Med 2008;6:19.
   PubMed Web of Science ®Google Scholar
• Hoeller S, Schneider A, Haralambieva E, FOXP1 protein overexpression is associated with inferior outcome in nodal diffuse large B-cell lymphomas with non-germinal centre phenotype, independent of gains and structural aberrations at 3p14.1. Histopathology 2010;57(1):73–80.
   Web of Science ®Google Scholar